Skip to Content

M D 34 (Doxycycline Hyclate Delayed-Release 200 mg)

Pill with imprint M D 34 is White, Capsule-shape and has been identified as Doxycycline Hyclate Delayed-Release 200 mg. It is supplied by Mylan Pharmaceuticals Inc..

Doxycycline is used in the treatment of acne; actinomycosis; anthrax; amebiasis; gonococcal infection, uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M D 34

Doxycycline hyclate delayed-release 200 mg M D 34

Doxycycline Hyclate Delayed-Release

M D 34
200 mg
21.00 mm
Prescription only
Drug Class
Miscellaneous antimalarials, Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, silicon dioxide, lactose monohydrate, povidone, corn starch, sodium chloride, sodium lauryl sulfate, stearic acid, magnesium silicate, triethyl citrate, hypromellose phthalate (24% phthalate, 55 cst)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M D 34"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.